In COVID-19 affected mothers’ samples of BM, anti-RBD IgA and IgG, anti-spike S2 and antinucleocapsid (N) IgG, and IgG anti-HCoVOC43 were detected, higher than pre-pandemic samples [11]. This evidence concerns the gene CD79A and COVID-19.